KTYCF (Kits Eyecare) 1-Year Sharpe Ratio: -0.11 (As of Jul. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KTYCF Kits Eyecare Ltd KTYCF
74 GF Score
Price $9.52
GF Value $9.64
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Kits Eyecare 1-Year Sharpe Ratio?

Kits Eyecare KTYCF -2.36% 74 1-Year Sharpe Ratio is -0.11 as of Jul. 20, 2026. GuruFocus rates KTYCF with a GF Score™ of 74/100 and a GF Value™ of $9.64 (Fairly Valued). The stock has 1 warning sign investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-20), Kits Eyecare's 1-Year Sharpe Ratio is -0.11.


Kits Eyecare  (OTCPK:KTYCF) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Kits Eyecare 1-Year Sharpe Ratio Related Terms


KTYCF vs CASY, WSM, DKS: 1-Year Sharpe Ratio Comparison

For the Specialty Retail subindustry, Kits Eyecare's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kits Eyecare 1-Year Sharpe Ratio vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Kits Eyecare's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Kits Eyecare's 1-Year Sharpe Ratio falls into.


KTYCF
74GF Score
Kits Eyecare Ltd KTYCF
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kits Eyecare 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -0.11 mean?
Kits Eyecare (KTYCF) has a 1-Year Sharpe Ratio of -0.11 as of Jul. 20, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Kits Eyecare and its competitors.
Is Kits Eyecare's 1-Year Sharpe Ratio too high?
Kits Eyecare's current 1-Year Sharpe Ratio is -0.11. Overall, Kits Eyecare has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kits Eyecare's 1-Year Sharpe Ratio compare to CASY and WSM?
Kits Eyecare's 1-Year Sharpe Ratio of -0.11 can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Retail - Cyclical company?
A good 1-Year Sharpe Ratio depends on the Retail - Cyclical industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Kits Eyecare and its competitors. Kits Eyecare's current 1-Year Sharpe Ratio is -0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kits Eyecare stock overvalued right now?
Based on GuruFocus' analysis, Kits Eyecare (KTYCF) is currently considered Fairly Valued. The stock's GF Value™ is $9.64, compared to a current price of $9.52 — trading 1.2% below its estimated fair value. The current 1-Year Sharpe Ratio is -0.11. Kits Eyecare's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Kits Eyecare (KTYCF), the current 1-Year Sharpe Ratio is -0.11 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kits Eyecare (KTYCF) Overvalued in 2026?

Based on GuruFocus' analysis, Kits Eyecare stock appears to be undervalued. The current stock price of $9.52 is trading 1.2% below its estimated GF Value™ of $9.64. GuruFocus considers Kits Eyecare to be Fairly Valued.

Key valuation signals for KTYCF:

  • 1-Year Sharpe Ratio: -0.11
  • GF Value™: $9.64 vs. price of $9.52 (1.2% below fair value)
  • GF Score™: 74/100 with 1 warning sign

No single metric tells the full story. See the KTYCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kits Eyecare Business Description

Other Exchanges 0P3:GermanyKITS:Canada
Address 510 Seymour Street, Suite 1020, Vancouver, BC, CAN, V6B 3J5
Kits Eyecare Ltd is a vertically integrated, digitally native eyecare platform that offers its customers access to a vast selection of the highest quality contact lenses and eyeglasses, including its exclusive KITS-designed products, and a suite of online vision tools. It operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. The company's contact lens partners include Alcon, Bausch & Lomb, CooperVision, and Johnson & Johnson, and its glasses partners include Gucci, Oakley, Prive Revaux, Ray-Ban and Tom Ford. Its geographic locations are the United States; and Canada and Other which generates the majority of its revenue from the United States.
74GF Score

Get the complete analysis for KTYCF

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.52
Price
$9.64
GF Value